Alivus Life Sciences Limited — Updates, 20-08-2025: General Updates
20-08-2025 | 02:24 pm
20-08-2025 | 02:24 pm
Alivus Life Sciences received a customs order imposing approx. ₹3.22 Cr in fines and penalties for alleged mis-classification of goods. The company states no material financial or operational impact and plans to appeal. Investors should monitor the appeal outcome.
No comments yet. Be the first to comment!
